Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients
PSMA-RGS is a promising treatment option to enhance salvage surgery in early biochemical recurrence. However, only 42% of the patients treated with PSMA RGS remain without a biochemical recurrence. Further research is mandatory to identify patients, who profit from PSMA-RGS.
Authors
- J Moosbauer (ORCID: https://orcid.org/0009-0002-9036-7430)
- D. Hellwig (ORCID: https://orcid.org/0000-0002-3056-0143)
- Marco J. Schnabel (ORCID: https://orcid.org/0000-0002-1535-2952)
- Jirka Grosse (ORCID: https://orcid.org/0000-0002-9130-0804)
- Simon Engelmann (ORCID: https://orcid.org/0000-0003-3810-3307)
- Maximilian Haas (ORCID: https://orcid.org/0000-0003-3132-0130)
- Roman Mayr (ORCID: https://orcid.org/0000-0003-1796-3260)
- Johannes Breyer (ORCID: https://orcid.org/0000-0003-0674-4150)
- Stefan Denzinger
- Yushan Yang
- D Schmidt (ORCID: https://orcid.org/0000-0001-8767-3723)
- Matthias Eiber (ORCID: https://orcid.org/0000-0003-2654-6872)
- Thomas Schmid
- Maximilian Burger (ORCID: https://orcid.org/0009-0005-5013-9435)
Institutions
- University of Regensburg (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- World Journal of Urology
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1007/s00345-024-05189-6
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Universitätsklinikum Regensburg